NEXT-GENERATION sequencing use rose in advanced cancer, but access remained uneven across socioeconomic, racial, and ...

"In our study, we showed that fine needle aspiration (FNA) biopsy material can be a good source for next-generation sequencing (NGS) for patients with metastatic prostate cancer. Based on these ...

In this cohort study, most patients with advanced or metastatic cancers did not undergo tumor genomic testing. Low socioeconomic status, Black race or Hispanic ethnicity, and Medicaid or Medicare ...

Scientists at Pitt developed BiliSeq in 2019, a molecular test that detects both DNA and RNA sequences in biopsy samples to ...

Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive ...

In this cohort study, most patients with advanced or metastatic cancers did not undergo tumor genomic testing. Low socioeconomic ...

Tissue Cryopreservation Preserves More Future Options The way a patient's tumor tissue is preserved after surgery is ...

A study led by researchers at a community hospital in Sapporo, Japan found that comprehensive genomic testing using a ...

DELFI Diagnostics, Inc., developer of innovative blood-based tests that leverage whole-genome cell-free DNA (cfDNA) assays for cancer detection and monitoring, today announced it will present five ...

Next-Generation Oncology Devices and Solutions Market · GlobeNewswire Inc. The next-generation oncology devices and solutions ...